Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival
Authors:
Open Access
- 25 May 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 106 (9) , 1324-1329
Abstract
Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVE: To study guideline recommendation (GR)‐concordance rates of treatment in elderly patients with urothelial carcinoma of the bladder (UCB) and to identify predictors of survival. PATIENTS AND METHODS: The records of 206 consecutive patients aged ≥75 years (median age 79 years; range 75–95) were reviewed. All patients underwent transurethral resection (TUR) or biopsy of UCB. The European Association of Urology and American Urological Association guidelines were used as reference when evaluating concordance with GRs and clinical outcome. Univariable and multivariable analyses were performed to identify predictors of survival. RESULTS: The overall GR‐concordance rate of treatment was 88.8% (183 of 206 patients). Patients who were older ( P = 0.017), who underwent prior treatment for UCB ( P = 0.010), and had greater comorbidities ( P = 0.001) were less likely to undergo treatment following GRs. With a median (mean; range) follow‐up of 14.7 (22.6; 0.3–111.5) months, 79 patients died (38.3%). More comorbidities (unadjusted Charlson comorbidity index; P = 0.007), a Karnofsky performance status (KPS) score of ≤80 ( P = 0.001) and more advanced initial pathological tumour stage ( P = 0.019) independently predicted reduced overall survival (OS). In the subgroup of patients with indication for cystectomy ( n = 99), there was a trend for longer OS in patients treated with curative intent (cystectomy or radio‐chemotherapy) compared with conservative treatment with TUR ± intravesical therapy only ( P = 0.095). CONCLUSIONS: The vast majority of elderly patients with UCB received adequate treatment at our tertiary institution. The KPS score, more comorbidities and more advanced pathological tumour stage are predictors for reduced OS and should be considered to optimize patient care.Keywords
This publication has 15 references indexed in Scilit:
- Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?BJU International, 2008
- Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancerCancer, 2008
- Performance Status is a Predictor of Overall Survival of Elderly Patients With Muscle Invasive Bladder CancerJournal of Urology, 2007
- Age and comorbidity impact surgical therapy in older bladder carcinoma patientsCancer, 2005
- Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly StudyJournal of Clinical Oncology, 2005
- Radical cystectomy in the elderlyCancer, 2005
- The Impact Of Co-morbid Disease on Cancer Control and Survival Following Radical CystectomyJournal of Urology, 2003
- RADICAL CYSTECTOMY IS SAFE IN ELDERLY PATIENTS AT HIGH RISKJournal of Urology, 2001
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderAmerican Journal of Surgical Pathology, 1998
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987